Pharsight

Feraheme generic

Feraheme is an iron delivery drug owned by Covis. The active ingredient in Feraheme is ferumoxytol. Feraheme was first authorized for market use on June 30, 2009.

When will Feraheme generic be available?

The generic release date of Feraheme could potentially be after June 30, 2023. This is based on the expiry date of the last patent, US6599498, named as Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohydrate derivatives, which is expected to expire on June 30, 2023.

Feraheme uses

Feraheme is used for the treatment of iron deficiency anemia in adult patients who have intolerance to oral iron or have had unsatisfactory response to oral iron. Its active ingredient, ferumoxytol, replenishes iron stores in your body and helps improve symptoms of anemia.

Feraheme patent expiration

Feraheme holds a total of 1 drug patent, which has already expired. The patent, US6599498, was titled as 'Heat stable colloidal iron oxides coated with reduced carbohydrates and carbohydrate derivatives', and its expiry date was June 30, 2023. Hence, it's possible that the Feraheme generic could be available upon further approvals after June 30, 2023. Below are the details of the patent:

Feraheme dosage

Want to ask something?